J. I. Weitz

发表

The benefit‐to‐risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model

J. Rak, M. Johnston, P. Klement, 2003, Journal of thrombosis and haemostasis : JTH.

Active metabolite concentration of clopidogrel in patients taking different doses of aspirin: results of the interaction trial

J. Hirsh, J. Eikelboom, G. Paré, 2015, Journal of thrombosis and haemostasis : JTH.

Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

J. I. Weitz, Jack Hirsh, J. W. Eikelboom, 2014 .

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

H. Krumholz, W. Ageno, G. Stone, 2020, Thrombosis and Haemostasis.

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

A. Parkhomenko, E. Antman, M. Ezekowitz, 2014, The Lancet.

Antithrombotic activity of the novel oral anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in animal models.

P. Druzgala, J. Weitz, S. Bowersox, 2010, Thrombosis research.

Heparan sulfate: antithrombotic or not?

J. Weitz, J. I. Weitz, 2003, The Journal of clinical investigation.

Hypersulfated Low Molecular Weight Heparin with Reduced Affinity for Antithrombin Acts as an Anticoagulant by Inhibiting Intrinsic Tenase and Prothrombinase*

J. Hirsh, J. Weitz, V. Ghazarossian, 2001, The Journal of Biological Chemistry.

Global public awareness of venous thromboembolism

G. Raskob, E. Hylek, H. Buller, 2015, Journal of thrombosis and haemostasis : JTH.

New antithrombotic agents.

J. Hirsh, J. Weitz, J. I. Weitz, 1998, Chest.

A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats.

J. Hirsh, M. Andrew, J. Weitz, 1997, Blood.

Activation of blood coagulation by plaque rupture: mechanisms and prevention.

J. Weitz, J. I. Weitz, 1995, The American journal of cardiology.

New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

J. Eikelboom, M. Samama, J. Weitz, 2012, Chest.

The Antidote for Reversal of Dabigatran

J. Eikelboom, J. Weitz, J. van Ryn, 2015 .

Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.

J. Eikelboom, J. Weitz, D. Quinlan, 2013, Circulation.